Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Forrest

Showing results (31-40 of 400) with videos related to

Pageof 40
Sort By:
Nursing Times|April 18, 1974
Acute poisoningJ A Forrest
The British Journal of Clinical Practice|May 1, 1972
A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release studyW A Forrest
The British Journal of Clinical Practice|November 1, 1977
Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patientsW A Forrest
Current Medical Research and Opinion|January 1, 1978
Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departmentsW A Forrest
The British Journal of Clinical Practice|December 1, 1975
A double-blind clinical trial in angina pectoris. A comparison between oxprenolol, practolol and placeboW A Forrest
Journal of American College Health : J of ACH|June 21, 2001
Men's reproductive and sexual healthK A Forrest
The Journal of International Medical Research|January 1, 1979
Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practiceW A Forrest
The British Journal of Clinical Practice|September 1, 1973
Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice studyW A Forrest
Oncogene|July 24, 2001
Cdc25B activity is regulated by 14-3-3A Forrest, B Gabrielli
Autonomic & Autacoid Pharmacology|December 24, 2003
The enhanced spontaneous activity of the diabetic colon is not the consequence of impaired inhibitory control mechanismsA Forrest, M Parsons
Pageof 40

Showing results (31-40 of 400) with videos related to

Sort By:
Pageof 40
Nursing Times|April 18, 1974
Acute poisoningJ A Forrest
The British Journal of Clinical Practice|May 1, 1972
A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release studyW A Forrest
The British Journal of Clinical Practice|November 1, 1977
Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patientsW A Forrest
Current Medical Research and Opinion|January 1, 1978
Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departmentsW A Forrest
The British Journal of Clinical Practice|December 1, 1975
A double-blind clinical trial in angina pectoris. A comparison between oxprenolol, practolol and placeboW A Forrest
Journal of American College Health : J of ACH|June 21, 2001
Men's reproductive and sexual healthK A Forrest
The Journal of International Medical Research|January 1, 1979
Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practiceW A Forrest
The British Journal of Clinical Practice|September 1, 1973
Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice studyW A Forrest
Oncogene|July 24, 2001
Cdc25B activity is regulated by 14-3-3A Forrest, B Gabrielli
Autonomic & Autacoid Pharmacology|December 24, 2003
The enhanced spontaneous activity of the diabetic colon is not the consequence of impaired inhibitory control mechanismsA Forrest, M Parsons
Pageof 40